Overview
Spondyloepiphyseal dysplasia (SED) and spondyloepimetaphyseal dysplasia (SEMD) are a heterogeneous group of inherited skeletal disorders (osteochondrodysplasias) characterized by abnormal development of the spine (spondylo-), the ends of long bones (epiphyseal), and in the case of SEMD, also the growing portions of long bones (metaphyseal). These conditions primarily affect the skeletal system, leading to disproportionate short stature with a short trunk, abnormalities of the vertebral bodies (platyspondyly), and variable involvement of the limbs. The group encompasses multiple distinct subtypes, including spondyloepiphyseal dysplasia congenita (SEDc, caused by COL2A1 mutations), spondyloepiphyseal dysplasia tarda (SEDT, often X-linked due to TRAPPC2 mutations), and numerous forms of SEMD with varying genetic causes. Clinical features vary by subtype but commonly include short stature, barrel chest, kyphoscoliosis, lumbar lordosis, coxa vara, genu valgum, and joint pain or stiffness. Many patients develop early-onset osteoarthritis. Ocular complications such as myopia and retinal detachment can occur in COL2A1-related forms. Odontoid hypoplasia with cervical instability is a potentially serious complication in some subtypes, particularly SEDc, and may lead to spinal cord compression. Some forms are associated with hearing loss or cleft palate. There is currently no cure for SED or SEMD. Treatment is supportive and multidisciplinary, involving orthopedic management of skeletal deformities (including surgical correction of scoliosis, hip replacement, or cervical spine stabilization when needed), ophthalmologic monitoring, pain management, and physical therapy. Regular surveillance for cervical spine instability is critical in certain subtypes. Genetic counseling is recommended for affected families, as the inheritance pattern and prognosis vary significantly depending on the specific subtype and underlying genetic cause.
Also known as:
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia.
Community
No community posts yet. Be the first to share your experience with Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia.
Start the conversation →Latest news about Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia
No recent news articles for Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia
What is Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia?
Spondyloepiphyseal dysplasia (SED) and spondyloepimetaphyseal dysplasia (SEMD) are a heterogeneous group of inherited skeletal disorders (osteochondrodysplasias) characterized by abnormal development of the spine (spondylo-), the ends of long bones (epiphyseal), and in the case of SEMD, also the growing portions of long bones (metaphyseal). These conditions primarily affect the skeletal system, leading to disproportionate short stature with a short trunk, abnormalities of the vertebral bodies (platyspondyly), and variable involvement of the limbs. The group encompasses multiple distinct subtyp